Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4125 USD | +8.68% | +10.00% | -78.85% |
05-15 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M | MT |
03-28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-78.85% | 2.6M | |
+7.29% | 113B | |
+11.16% | 106B | |
+0.41% | 22.27B | |
-11.94% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
-6.34% | 17.24B | |
+6.94% | 14.29B | |
+34.70% | 12.52B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics : Oppenheimer Adjusts Price Target for Agile Therapeutics to $4 From $6, Maintains Outperform Rating